Improvement of fibrosis is associated with the decrease of collagen III formation biomarker Pro-C3 in patients with non-alcoholic steatohepatitis

被引：0

作者：

Luo, Yi ^{[1
]}

Vincent, Robert ^{[2
]}

Gagnon, Robert C. ^{[1
]}

Charles, Edgar D. ^{[1
]}

Oseini, Abdul ^{[2
]}

Mirshahi, Faridoddin ^{[2
]}

Banini, Bubu A. ^{[2
]}

Daita, Kalyani ^{[2
]}

Idowu, Michael O. ^{[2
]}

Rosen, Glenn D. ^{[1
]}

Jarai, Gabor ^{[1
]}

Christian, Rose ^{[1
]}

Sanyal, Arun J. ^{[2
]}

机构：

[1] Bristol Myers Squibb, Lawrenceville, NJ USA

[2] Virginia Commonwealth Univ, Richmond, VA USA

来源：

HEPATOLOGY | 2017年 / 66卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

633

引用

页码：345A / 345A

页数：1

共 50 条

[21] A Biomarker Panel for Non-alcoholic Steatohepatitis (NASH) and NASH-Related Fibrosis
Younossi, Zobair M.
Page, Sandra
Rafiq, Nila
Birerdinc, Aybike
Stepanova, Maria
Hossain, Noreen
Afendy, Arian
Younoszai, Zahra
Goodman, Zachary
Baranova, Ancha
OBESITY SURGERY, 2011, 21 (04) : 431 - 439
[22] Independent Predictors of Steatohepatitis and Fibrosis in Asian Indian Patients with Non-Alcoholic Steatohepatitis
Deepak Kumar Singh
Puja Sakhuja
Veena Malhotra
Ranjana Gondal
Shiv Kumar Sarin
Digestive Diseases and Sciences, 2008, 53 : 1967 - 1976
[23] Independent predictors of steatohepatitis and fibrosis in Asian Indian patients with non-alcoholic steatohepatitis
Singh, Deepak Kumar
Sakhuja, Puja
Malhotra, Veena
Gondal, Ranjana
Sarin, Shiv Kumar
DIGESTIVE DISEASES AND SCIENCES, 2008, 53 (07) : 1967 - 1976
[24] Free Light Chains as a potential biomarker of inflammation and fibrosis in non-alcoholic steatohepatitis
Liguori, Antonio
Basile, Umberto
Napodano, Cecilia
Tomasello, Lidia
Mancuso, Fabrizio
Di Gialleonardo, Luca
Marrone, Giuseppe
Biolato, Marco
Gasbarrini, Antonio
Rapaccini, Gian Ludovico
Grieco, Antonio
Miele, Luca
JOURNAL OF HEPATOLOGY, 2022, 77 : S436 - S436
[25] A Biomarker Panel for Non-alcoholic Steatohepatitis (NASH) and NASH-Related Fibrosis
Zobair M. Younossi
Sandra Page
Nila Rafiq
Aybike Birerdinc
Maria Stepanova
Noreen Hossain
Arian Afendy
Zahra Younoszai
Zachary Goodman
Ancha Baranova
Obesity Surgery, 2011, 21 : 431 - 439
[26] Serum Pro-C3 combined with clinical parameters is superior to established serological fibrosis tests at identifying patients with advanced fibrosis among patients with non-alcoholic fatty liver disease
Daniels, S. J.
Nielsen, M. J.
Krag, A.
Eslam, M.
Karsdal, M. A.
Leeming, D. J.
George, J.
JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S671 - S671
[27] Changes in Serum Bile Acids Correlate with 7alpha-Hydroxy-4-Cholesten-One and Fibrogenesis Biomarker Pro-C3 with NGM282 Therapy in Patients with Non-alcoholic Steatohepatitis
Sanyal, Arun
Ling, Lei
Jaros, Mark
Baxter, Bryan
Kowdley, Kris V.
DePaoli, Alex
Harrison, Stephen
JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E156 - E156
[28] Aminotransferase improvements in patients with non-alcoholic steatohepatitis are associated with fibrosis regression in the REGENERATE study
Rinella, Mary
Dufour, Jean-Francois
Anstee, Quentin
Younossi, Zobair
Loomba, Rohit
Sanyal, Arun
Capozza, Thomas
Granston, Tanya
Bonacci, Martin
Trylesinski, Aldo
Ratziu, Vlad
JOURNAL OF HEPATOLOGY, 2021, 75 : S625 - S626
[29] Percent Change in Plasma Collagen Type III Formation (PRO-C3) Is Related to Change in Liver Fibrosis Stage: Centaur Study
Leeming, Diana J.
Birot, Sophie
Goodman, Zachary D.
Friedman, Scott L.
McKibben, Andrew
Seyedkazemi, Star
Muthian, Sean
Fischer, Laurent
Karsdal, Morten
Sanyal, Arun J.
Ratziu, Vlad
HEPATOLOGY, 2018, 68 : 1315A - 1315A
[30] REDUCTION OF DAILY MODERATE ALCOHOL INTAKE PREDICTED TO DECREASE FIBROSIS STAGE IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS
Battista, Christina M.
Beaudoin, James
Yang, Kyunghee
Siler, Scott Q.
HEPATOLOGY, 2022, 76 : S766 - S767

← 1 2 3 4 5 →